Anthrax Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anthrax. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions... Research Beam Model: Research Beam Product ID: 153542 2500 USD New
Anthrax Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Anthrax Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 77
 
 
Anthrax Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anthrax. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anthrax 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Anthrax 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Anthrax Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Anthrax 27
Sep 22, 2014: Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 27
Aug 07, 2014: Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax 28
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Emergent BioSolutions Inc. 30
Clinical Trial Overview of Emergent BioSolutions Inc. 30
PharmAthene, Inc. 31
Clinical Trial Overview of PharmAthene, Inc. 31
Elusys Therapeutics, Inc. 32
Clinical Trial Overview of Elusys Therapeutics, Inc. 32
PaxVax 33
Clinical Trial Overview of PaxVax 33
Panacea Biotec Limited 34
Clinical Trial Overview of Panacea Biotec Limited 34
Human Genome Sciences, Inc. (Inactive) 35
Clinical Trial Overview of Human Genome Sciences, Inc. (Inactive) 35
Green Cross Holdings Corporation 36
Clinical Trial Overview of Green Cross Holdings Corporation 36
Defence Science and Technology Laboratory 37
Clinical Trial Overview of Defence Science and Technology Laboratory 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
Bavarian Nordic A/S 39
Clinical Trial Overview of Bavarian Nordic A/S 39
Clinical Trial Overview of Top Institutes / Government 40
The National Institute of Allergy and Infectious Diseases 40
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 40
Fraunhofer Center for Molecular Biotechnology 41
Clinical Trial Overview of Fraunhofer Center for Molecular Biotechnology 41
Eunice Kennedy Shriver National Institute of Child Health and Human Development 42
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 42
Seoul National University Hospital 43
Clinical Trial Overview of Seoul National University Hospital 43
National Institutes of Health Clinical Center 44
Clinical Trial Overview of National Institutes of Health Clinical Center 44
Centers for Disease Control and Prevention 45
Clinical Trial Overview of Centers for Disease Control and Prevention 45
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
Duke University 47
Clinical Trial Overview of Duke University 47
Five Key Clinical Profiles 48
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77
List Of Tables
List of Tables
Anthrax Therapeutics, Global, Clinical Trials by Region, 2014* 7
Anthrax Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anthrax Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anthrax Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Anthrax Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Anthrax Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Anthrax to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Anthrax Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anthrax Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anthrax to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Anthrax Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Anthrax Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Anthrax Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Anthrax Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Anthrax Therapeutics, Global, Suspended Clinical Trials, 2014* 21
Anthrax Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Anthrax Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Anthrax Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Anthrax Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Anthrax Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Anthrax Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 30
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmAthene, Inc., 2014* 31
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Elusys Therapeutics, Inc., 2014* 32
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by PaxVax, 2014* 33
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2014* 34
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Human Genome Sciences, Inc. (Inactive), 2014* 35
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Holdings Corporation, 2014* 36
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Defence Science and Technology Laboratory, 2014* 37
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Bavarian Nordic A/S, 2014* 39
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 40
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraunhofer Center for Molecular Biotechnology, 2014* 41
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 42
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 43
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 44
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014* 45
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 46
Anthrax Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 47
List Of Figures
List of Figures
Anthrax Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Anthrax Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anthrax Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anthrax Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Anthrax Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Anthrax to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Anthrax Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anthrax Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anthrax to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Anthrax Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Anthrax Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Anthrax Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Anthrax Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Anthrax Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Anthrax Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Anthrax Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Anthrax Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Anthrax Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 76